Ali Brocato is the co-founder and CEO of Beakr, an AI platform that learns how life sciences teams actually work and turns that into executable knowledge - making experimentation computable, reusable, and compounding. She completed a combined BS/MS in Biomedical Engineering at Yale in three and a half years, building two companies along the way: Simplex Sciences, now the largest supplier of ssDNA ladders to academic and industry labs, and ADVANCE, an AI-powered nurse-patient communication platform with Yale New Haven Health. She published her first research at 17 during a study at the Harvard Stem Cell Institute. Most recently before Beakr, Ali was a growth investor at General Atlantic evaluating software and healthtech companies - giving her a rare vantage point as a founder who has built, published, and invested across the life sciences stack.